抗病毒药物耐药性市场策略、顶级参与者、增长机会、2031 年分析和预测

  • Report Code : TIPRE00006395
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

抗病毒药物耐药性市场规模预计将从 2023 年的 34.4 亿美元增至 2031 年的 63.5 亿美元。预计 2023-2031 年市场复合年增长率为 7.9%。肝病发病率的上升、艾滋病毒和艾滋病的流行以及新兴国家对高质量产品的需求可能仍然是市场的主要趋势。

抗病毒药物耐药性市场分析

近年来,艾滋病毒/艾滋病的患病率在世界范围内有所增加。获得性免疫缺陷综合症(艾滋病)是一种慢性的、可能危及生命的疾病,由人类免疫缺陷病毒(HIV)引起。该病毒会损害免疫系统,从而干扰人体抵抗致病微生物的能力。当艾滋病毒进入人体后,它会在一个月内出现类似流感的疾病。这种疾病被称为原发性或急性艾滋病毒感染,可能持续几周。根据美国卫生与公众服务部提供并得到部长少数民族艾滋病倡议基金 (SMAIF) 支持的数据,到 2022 年,大约全世界有 3900 万人感染艾滋病毒/艾滋病。绝大多数艾滋病毒感染者生活在低收入和中等收入国家。例如,根据2017年印度艾滋病毒估计报告(国家信息学中心),印度的艾滋病毒患病率估计为0.22%(0.16%–0.30%)。此外,成人艾滋病毒感染率男性中估计为 0.25%(0.18%-0.34%),女性中为 0.19%(0.14-0.25)。因此,预计该国的病毒感染病例将在预测期内推动抗病毒药物耐药性市场的需求

抗病毒药物耐药性市场概况

多年来,肝炎疾病发病率的上升和艾滋病毒/艾滋病患病率的上升正在推动市场的增长。此外,新兴市场的增长可能会对预测期内的市场需求产生积极影响。然而,市场的增长受到替代方法等因素的限制。近年来,美国艾滋病毒感染率有所上升。根据美国卫生与公众服务部提供并得到国务卿少数族裔艾滋病倡议基金 (SMAIF) 支持的数据,2021 年,近 32,100 名美国人新感染艾滋病毒。因此,上述因素预计将加剧预测期内北美抗病毒药物耐药性市场的增长。

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

抗病毒药物耐药性市场:

抗病毒药物耐药性市场
  • Antiviral Drug Resistance Market
    年均复合增长率(2023 - 2031)
    7.9%
  • 2023 年市场规模
    34.4 亿美元
  • 2031 年市场规模
    63.5 亿美元

市场动态

增长动力
  • 肝病发病率上升利好市场
未来的趋势
  • 艾滋病毒/艾滋病患病率不断上升
机会
  • 新兴市场医疗保健支出增加

关键人物;主力;重要一员

  • AccuBioTech有限公司;
  • 艾康实验室有限公司;
  • 西门子公司;
  • 生物梅里埃公司;
  • Bio-Rad 实验室公司;
  • 丹纳赫;
  • 雅培;
  • BD ;
  • F霍夫曼-拉罗氏有限公司;
  • 三一生物科技

区域概况

Antiviral Drug Resistance Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Antiviral Drug Resistance Market产品
  • 试剂盒和试剂
  • 仪器
  •  
Antiviral Drug Resistance Market疾病适应症
  • 人类免疫缺陷病毒
Antiviral Drug Resistance Market技术
  • 免疫诊断
  • 聚合酶链式反应
Antiviral Drug Resistance Market最终用户
  • 医院和诊所
  • 病理学或诊断实验室
  • 研究机构
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

抗病毒药物耐药性市场驱动因素和机遇

肝病发病率上升有利于市场

病毒是一种微小的细菌,可以引起多种传染病,例如流感、普通感冒和疣。病毒还可引起严重疾病,包括天花、艾滋病毒/艾滋病和埃博拉病毒。病毒在细胞内繁殖,能够进入任何活的、健康的细胞并繁殖并产生类似病毒的其他病毒。不同的病毒攻击体内的特定细胞,如肝脏、大脑、皮肤、血液以及生殖、呼吸和胃肠系统。近年来,肝炎等病毒感染的患病率在全球范围内有所增加。肝炎会导致肝脏损伤和炎症,也会损害其他器官。这是一个主要的全球健康问题,可导致慢性感染,并增加肝硬化和肝癌死亡的风险。肝炎可分为甲型、乙型、丙型、丁型和戊型肝炎,通过不同原因传播。据世界卫生组织(WHO)统计,非洲和西太平洋地区乙型肝炎患病率最高,分别有6.1%和6.2%的成年人口受到感染。

新兴市场医疗保健支出增加

亚太地区、南美洲和中美洲等新兴经济体不断增加的医疗保健支出使研究人员能够利用 PCR(聚合酶链式反应)、新一代测序等先进技术开发多种病毒性疾病的治疗方案。美国国家癌症研究所 (NCI) 等多个组织资助了艾滋病毒和艾滋病恶性肿瘤研究,以研究慢性艾滋病毒感染下的衰老如何影响癌症的风险、谱系和生物学。中国、日本、巴西和其他新兴国家在医疗保健支出上投入巨资,以建立自己的市场地位,并确保各自国家的医院、研究机构、病理实验室和其他目的地使用的仪器和试剂得到适当使用。

抗病毒药物耐药性市场报告细分分析

有助于抗病毒药物耐药性市场分析的关键部分是类型、疾病适应症、技术和最终用户。

  • 根据类型,抗病毒耐药市场分为试剂盒和试剂和仪器。 2023 年,试剂盒和试剂细分市场占据最大市场份额。
  • 按疾病适应症,市场分为艾滋病毒、肝炎和巨细胞病毒(CMV)。 2023 年,艾滋病毒细分市场占据最大市场份额。
  • 就技术而言,市场分为免疫诊断、聚合酶链反应(PCR)、下一代测序(NGS)等。到 2023 年,免疫诊断领域将占据重要的市场份额。
  • 根据最终用户,抗病毒耐药市场分为医院和诊所、病理或诊断实验室和研究机构。 2023 年,医院和诊所细分市场占据最大市场份额。

按地域划分的抗病毒药物耐药性市场份额分析

抗病毒药物耐药性市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美洲和中美洲。按地理位置划分,北美在高流量鼻插管市场中拥有最大的市场份额。由于多种因素,例如艾滋病毒和肝炎等病毒感染的流行、国家计划的存在以及政府机构的资助,预计在预测期内,市场需求将大幅增长。近年来,美国艾滋病毒感染率有所上升。根据美国卫生与公众服务部提供并得到国务卿少数族裔艾滋病倡议基金 (SMAIF) 支持的数据,2021 年,近 32,100 名美国人新感染艾滋病毒。预计亚太地区将以全球复合年增长率最高的地区增长。未来几年。

抗病毒药物耐药性市场报告范围

报告属性细节
2023年市场规模34.4亿美元
2031 年市场规模63.5亿美元
全球复合年增长率(2023 - 2031)7.9%
历史数据2021-2022
预测期2024-2031
涵盖的细分市场按产品分类
  • 试剂盒和试剂
  • 仪器
  •  
按疾病适应症
  • 人类免疫缺陷病毒
按技术
  • 免疫诊断
  • 聚合酶链式反应
按最终用户
  • 医院和诊所
  • 病理学或诊断实验室
  • 研究机构
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • AccuBioTech有限公司;
  • 艾康实验室有限公司;
  • 西门子公司;
  • 生物梅里埃公司;
  • Bio-Rad 实验室公司;
  • 丹纳赫;
  • 雅培;
  • BD ;
  • F霍夫曼-拉罗氏有限公司;
  • 三一生物科技
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

抗病毒药物耐药性市场新闻和最新动态

抗病毒药物耐药性市场是通过收集初级和二级研究的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。下面列出了抗病毒药物耐药性市场的一些进展:

  • – 强生旗下杨森制药公司 (Janssen) 今天宣布,在《自然》杂志上发表的新数据显示,一种早期临床候选药物 (JNJ-1802) 可为非人类灵长类动物和小鼠提供针对登革热的强大保护。这种一流的抗病毒药物在第一阶段的首次人体临床研究中被证明是安全且耐受性良好的,目前正在进入预防和治疗登革热的第二阶段临床研究。 (来源:强生公司,新闻稿,2023 年 3 月)
  • Cipla Limited 宣布已获得印度药品监管总局(DCGI)授予的紧急使用授权(EUA)许可,可在该国推出 Molnupiravir。 Cipla 计划以 Cipmolnu® 品牌推出 Molnupiravir。 Molnupiravir 是英国药品和保健品监管局 (MHRA) 批准的第一种口服抗病毒药物,用于治疗具有发展为严重疾病的高风险的轻至中度 COVID-19。 (来源:Cipla,新闻稿,2021 年 5 月)

抗病毒药物耐药性市场报告范围和交付成果

《抗病毒药物耐药性市场规模及预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

  • 抗病毒耐药性市场规模以及全球、区域和国家层面涵盖的所有关键细分市场的预测
  • 抗病毒药物耐药性市场趋势以及市场动态,例如驱动因素、限制因素和关键机会
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 抗病毒耐药性市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,包括市场集中度、热图分析、知名参与者以及抗病毒耐药性市场的最新发展
  • 详细的公司简介
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the Antiviral Drug Resistance market in 2023?

Based on geography, the antiviral drug resistance market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global antiviral drug resistance market. Asia Pacific is expected to register the highest CAGR in the antiviral drug resistance market during 2023–2031

What are the driving factors impacting the Antiviral Drug Resistance market?

Risisng in the incidences of hepatitis diseases followed by increasing prevalence of HIV and AIDS largely drive the antiviral drug resistance market size

Which are the leading players operating in the Antiviral Drug Resistance market?

The Antiviral Drug Resistance market majorly consists of players such AccuBioTech Co., Ltd.; ACON Laboratories, Inc.; Siemens AG; BioMérieux SA; Bio-Rad Laboratories, Inc.; Danaher; Abbott; BDF. Hoffmann-La Roche Ltd.; and Trinity Biotech.

What would be the estimated value of the Antiviral Drug Resistance market by 2031?

The antiviral drug resistance market size is projected to reach US$ 6.35 billion by 2031

What is the expected CAGR of the Antiviral Drug Resistance market?

The market is expected to register a CAGR of 7.9% during 2023–2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.